2019 Cancer Innovation Pilot Awardees Announced

The Case Comprehensive Cancer Center (Case CCC) has made pilot award selections following a recent RFA. Selected projects were recognized as highly innovative and impactful, and likely to generate key data for larger, nationally competitive grants. Investigators were permitted to submit transformative proposals for technology development, biological or therapeutic questions, novel concepts in catchment-based research, or topics with the potential to overturn dogma. Please join us in congratulating the awardees below.

Regulation of PARP1 Function in Breast Cancer by a tRNA Synthetase

Paul Fox, PhD

Immuno-nanoparticles for directing antitumor immunity against early metastasis

Efstathios Karathanasis, PhD

The Next Generation CAR T Cells to Reduce Off-tumor irAE

Fu-Sen Liang, PhD

Probing heterogeneity underlying the evolution of TKI resistance with single cell RNA sequencing

Jacob Scott, MD, PhD